Literature DB >> 1531396

Adhesion molecules on human tonsil dendritic cells.

T C Prickett1, J L McKenzie, D N Hart.   

Abstract

Dendritic cells are specialist antigen-presenting cells that have a unique ability to stimulate a primary T cell response. Activation of T cells by DC depends on the formation of cell clusters creating DC-T cell membrane contact that probably involves adhesion molecules. Monoclonal antibodies were used to study adhesion molecules on DC, including members of the integrin and immunoglobulin supergene families. DC expressed LFA-1, ICAM-1, LFA-3, and the Hermes antigen, but no other integrin or immunoglobulin supergene family adhesion molecules were detected using a sensitive immunoperoxidase staining technique. Monoclonal antibodies to LFA-1 alpha and LFA-1 beta inhibited DC-stimulated allogeneic T cell (MLR) responses by 75 +/- 12% and 74 +/- 8%, respectively, as did the anti-LFA-3 (56 +/- 3% inhibition) and anti-LFA-2 (60 +/- 5% inhibition) antibodies. Three different anti-ICAM-1 antibodies inhibited only to a limited degree (mean range 8-24%). The inhibitory effect of the LFA-1 and LFA-3 antibodies was maximal if added early to the MLR. The inhibitory effect of the different antibodies was associated with variable decreases in DC-T cell cluster stability. The simultaneous addition of monoclonal antibodies to MLRs and preincubation washing experiments established that DC have at least 3 independent adhesion ligand interactions (LFA-1-ICAM-1, ICAM-1-LFA-1, and LFA-3-CD2) with T cells. It seems likely that the additional ligand for LFA-1, ICAM-2, is expressed on DC and contributes significantly to DC-T cell adherence and T cell activation. The membrane mobility of these molecules may also be important in the DC-T cell activation process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531396     DOI: 10.1097/00007890-199202010-00041

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Expression of the RelB transcription factor correlates with the activation of human dendritic cells.

Authors:  G J Clark; S Gunningham; A Troy; S Vuckovic; D N Hart
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  Hodgkin's cells express a novel pattern of adhesion molecules.

Authors:  P A Ellis; D N Hart; B M Colls; J C Nimmo; J E MacDonald; H B Angus
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

3.  Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.

Authors:  A D McLellan; A Heiser; D N Hart
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

4.  The role of non-adhesive T-cell-accessory cell interactions in the induction of T-cell proliferative hyporesponsiveness.

Authors:  M A Ibrahim; B M Chain; D R Katz
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

5.  Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.

Authors:  B D Hock; G C Starling; P B Daniel; D N Hart
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 6.  RNA vaccines in cancer treatment.

Authors:  Anita Bringmann; Stefanie Andrea Erika Held; Annkristin Heine; Peter Brossart
Journal:  J Biomed Biotechnol       Date:  2010-06-01

7.  Isolation and generation of human dendritic cells.

Authors:  Smita Nair; Gerald E Archer; Thomas F Tedder
Journal:  Curr Protoc Immunol       Date:  2012-11

8.  Differential function of dendritic cells isolated from blood and lymph nodes.

Authors:  S Hill; J P Coates; I Kimber; S C Knight
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  Dendritic cells in synovial fluid of chronic inflammatory arthritis lack CD80 surface expression.

Authors:  K L Summers; P B Daniel; J L O'Donnell; D N Hart
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.